COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Search Result Details
Back to Search Results
One or more keywords in your search matched the following properties of
Jiang, Shibo
Item Type
Name
Concept
Antibodies, Neutralizing
Academic Article
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
Academic Article
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response.
Academic Article
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.
Academic Article
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020).
Academic Article
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
Academic Article
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2.
Academic Article
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Academic Article
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
Academic Article
The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus.
Academic Article
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD.
Academic Article
Identification of Human Single-Domain Antibodies against SARS-CoV-2.
Academic Article
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.
Academic Article
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.
Academic Article
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
Academic Article
Neutralizing antibodies for the treatment of COVID-19.